PAPER Zeng J, Wei M, Li T, Chen W, Feng Y, Shi R, Song Y, Zheng W, Ma W
SEARCH RESULTS
329940 RESULTS
PAPER Yamane T, Suzui S, Kitaura H, Takahashi-Niki K, Iguchi-Ariga SM, Ariga H
Transcriptional Activation of the Cholecystokinin Gene by DJ-1 through Interaction of DJ-1 with RREB1 and the Effect of DJ-1 on the Cholecystokinin Level in Mice.
PLoS One. 2013 Nov 5;8(11) PubMed: 24348900PAPER Bohnen NI, Albin RL, Müller ML, Chou K
Advances in Therapeutic Options for Gait and Balance in Parkinson's Disease.
US Neurol. 2011 Nov 1;7(2):100-108. PubMed: 24348751PAPER Merrison-Hort R, Borisyuk R
The emergence of two anti-phase oscillatory neural populations in a computational model of the Parkinsonian globus pallidus.
Front Comput Neurosci. 2013 Dec 2;7:173. PubMed: 24348374PAPER Gupta A, Balasubramani PP, Chakravarthy VS
Computational model of precision grip in Parkinson's disease: a utility based approach.
Front Comput Neurosci. 2013 Dec 2;7:172. PubMed: 24348373PAPER Grieb B, von Nicolai C, Engler G, Sharott A, Papageorgiou I, Hamel W, Engel AK, Moll CK
Decomposition of abnormal free locomotor behavior in a rat model of Parkinson's disease.
Front Syst Neurosci. 2013 Nov 27;7:95. PubMed: 24348346PAPER Grover ND, Limaye RP, Gokhale DV, Patil TR
Zonisamide: A review of the clinical and experimental evidence for its use in Parkinson's disease.
Indian J Pharmacol. 2013 Nov;45(6) PubMed: 24347760PAPER Santiago JA, Potashkin JA
A network approach to diagnostic biomarkers in progressive supranuclear palsy.
Mov Disord. 2013 Dec 17; PubMed: 24347522PAPER Peacock CA, Sanders GJ, Wilson KA, Fickes-Ryan EJ, Corbett DB, von Carlowitz KP, Ridgel AL
Introducing a multifaceted exercise intervention particular to older adults diagnosed with Parkinson's disease: a preliminary study.
Aging Clin Exp Res. 2013 Dec 18; PubMed: 24347123PAPER Canning CG
Rehabilitation in Parkinson's disease- the challenge to provide early and ongoing, evidence-based, patient-centred care.
Arq Neuropsiquiatr. 2013 Dec 1;71(12) PubMed: 24347008PAPER Amin RA, Robertson NP
Risk and sub phenotype in Parkinson's disease.
J Neurol. 2013 Dec 19; PubMed: 24346186PAPER Geed M, Garabadu D, Ahmad A, Krishnamurthy S
Silibinin pretreatment attenuates biochemical and behavioral changes induced by intrastriatal MPP(+) injection in rats.
Pharmacol Biochem Behav. 2013 Dec 15;117C PubMed: 24345573PAPER Ghezzi L, Scarpini E, Galimberti D
Disease-modifying drugs in Alzheimer's disease.
Drug Des Devel Ther. 2013 Dec 6;7:1471-8. PubMed: 24353405PAPER Caso F, Mandelli ML, Henry M, Gesierich B, Bettcher BM, Ogar J, Filippi M, Comi G, Magnani G, Sidhu M, Trojanowski JQ, Huang EJ, Grinberg LT, Miller BL, Dronkers N, Seeley WW, Gorno-Tempini ML
In vivo signatures of nonfluent/agrammatic primary progressive aphasia caused by FTLD pathology.
Neurology. 2014 Jan 21;82(3):239-47. Epub 2013 Dec 18 PubMed: 24353332PAPER Villemagne VL, Ng S, Cappai R, Barnham KJ, Fodero-Tavoletti MT, Rowe CC, Masters CL
La lunga attesa: towards a molecular approach to neuroimaging and therapeutics in Alzheimer's disease.
Neuroradiol J. 2006 Oct 19;19(4):453-74. PubMed: 24351248Current Filters
No filters selected